Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 169

1.

Long- and short-term association of low-grade systemic inflammation with cardiovascular mortality in the LURIC study.

Kälsch AI, Scharnagl H, Kleber ME, Windpassinger C, Sattler W, Leipe J, Krämer BK, März W, Malle E.

Clin Res Cardiol. 2019 Jul 1. doi: 10.1007/s00392-019-01516-9. [Epub ahead of print]

PMID:
31263995
2.

Serum concentrations of free fatty acids are associated with 3-month mortality in acute heart failure patients.

Degoricija V, Trbušić M, Potočnjak I, Radulović B, Pregartner G, Berghold A, Scharnagl H, Stojakovic T, Tiran B, Frank S.

Clin Chem Lab Med. 2019 Jun 7. pii: /j/cclm.ahead-of-print/cclm-2019-0037/cclm-2019-0037.xml. doi: 10.1515/cclm-2019-0037. [Epub ahead of print]

PMID:
31188747
3.

Allergic rhinitis is associated with complex alterations in high-density lipoprotein composition and function.

Trakaki A, Sturm GJ, Pregartner G, Scharnagl H, Eichmann TO, Trieb M, Knuplez E, Holzer M, Stadler JT, Heinemann A, Sturm EM, Marsche G.

Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Jun 8;1864(10):1280-1292. doi: 10.1016/j.bbalip.2019.06.007. [Epub ahead of print]

4.

Nutritional Lifestyle Intervention in Obese Pregnant Women, Including Lower Carbohydrate Intake, Is Associated With Increased Maternal Free Fatty Acids, 3-β-Hydroxybutyrate, and Fasting Glucose Concentrations: A Secondary Factorial Analysis of the European Multicenter, Randomized Controlled DALI Lifestyle Intervention Trial.

Harreiter J, Simmons D, Desoye G, Corcoy R, Adelantado JM, Devlieger R, Galjaard S, Damm P, Mathiesen ER, Jensen DM, Andersen LLT, Dunne F, Lapolla A, Dalfra MG, Bertolotto A, Wender-Ozegowska E, Zawiejska A, Mantaj U, Hill D, Jelsma JGM, Snoek FJ, Leutner M, Lackinger C, Worda C, Bancher-Todesca D, Scharnagl H, van Poppel MNM, Kautzky-Willer A.

Diabetes Care. 2019 Jun 10. pii: dc190418. doi: 10.2337/dc19-0418. [Epub ahead of print]

PMID:
31182492
5.

Subclinical inflammation, telomere shortening, homocysteine, vitamin B6, and mortality: the Ludwigshafen Risk and Cardiovascular Health Study.

Pusceddu I, Herrmann W, Kleber ME, Scharnagl H, Hoffmann MM, Winklhofer-Roob BM, März W, Herrmann M.

Eur J Nutr. 2019 May 25. doi: 10.1007/s00394-019-01993-8. [Epub ahead of print]

PMID:
31129702
6.

Atrial fibrillation is associated with alterations in HDL function, metabolism, and particle number.

Trieb M, Kornej J, Knuplez E, Hindricks G, Thiele H, Sommer P, Scharnagl H, Dagres N, Dinov B, Bollmann A, Husser D, Marsche G, Buettner P.

Basic Res Cardiol. 2019 May 8;114(4):27. doi: 10.1007/s00395-019-0735-0.

PMID:
31069509
7.

Lack of monoacylglycerol lipase prevents hepatic steatosis by favoring lipid storage in adipose tissue and intestinal malabsorption.

Tardelli M, Bruschi FV, Claudel T, Fuchs CD, Auer N, Kunczer V, Stojakovic T, Scharnagl H, Habib A, Grabner GF, Zimmermann R, Lotersztajn S, Trauner M.

J Lipid Res. 2019 Jul;60(7):1284-1292. doi: 10.1194/jlr.M093369. Epub 2019 May 2.

PMID:
31048404
8.

Iron Metabolism, Hepcidin, and Mortality (the Ludwigshafen Risk and Cardiovascular Health Study).

Grammer TB, Scharnagl H, Dressel A, Kleber ME, Silbernagel G, Pilz S, Tomaschitz A, Koenig W, Mueller-Myhsok B, März W, Strnad P.

Clin Chem. 2019 Jul;65(7):849-861. doi: 10.1373/clinchem.2018.297242. Epub 2019 Mar 27.

PMID:
30917972
9.

Treatment with PCSK9 inhibitors reduces atherogenic VLDL remnants in a real-world study.

Hollstein T, Vogt A, Grenkowitz T, Stojakovic T, März W, Laufs U, Bölükbasi B, Steinhagen-Thiessen E, Scharnagl H, Kassner U.

Vascul Pharmacol. 2019 May;116:8-15. doi: 10.1016/j.vph.2019.03.002. Epub 2019 Mar 23.

PMID:
30910670
10.

Cardiovascular risk algorithms in primary care: Results from the DETECT study.

Grammer TB, Dressel A, Gergei I, Kleber ME, Laufs U, Scharnagl H, Nixdorff U, Klotsche J, Pieper L, Pittrow D, Silber S, Wittchen HU, März W.

Sci Rep. 2019 Jan 31;9(1):1101. doi: 10.1038/s41598-018-37092-7.

11.

LDL triglycerides, hepatic lipase activity, and coronary artery disease: An epidemiologic and Mendelian randomization study.

Silbernagel G, Scharnagl H, Kleber ME, Delgado G, Stojakovic T, Laaksonen R, Erdmann J, Rankinen T, Bouchard C, Landmesser U, Schunkert H, März W, Grammer TB.

Atherosclerosis. 2019 Mar;282:37-44. doi: 10.1016/j.atherosclerosis.2018.12.024. Epub 2018 Dec 28.

PMID:
30685440
12.

Soluble urokinase plasminogen activation receptor and long-term outcomes in persons undergoing coronary angiography.

Sommerer C, Zeier M, Morath C, Reiser J, Scharnagl H, Stojakovic T, Delgado GE, März W, Kleber ME.

Sci Rep. 2019 Jan 24;9(1):475. doi: 10.1038/s41598-018-36960-6.

13.

HDL subclasses and mortality in acute heart failure patients.

Degoricija V, Potočnjak I, Gastrager M, Pregartner G, Berghold A, Scharnagl H, Stojakovic T, Tiran B, Marsche G, Frank S.

Clin Chim Acta. 2019 Mar;490:81-87. doi: 10.1016/j.cca.2018.12.020. Epub 2018 Dec 19.

14.

Recurrent tendosynovitis as a rare manifestation of a lipid disorder.

Wadsack D, Sattler H, Kleber ME, Eirich K, Scharnagl H, Fauler G, März W, Grammer TB.

J Clin Lipidol. 2019 Jan - Feb;13(1):54-61. doi: 10.1016/j.jacl.2018.10.005. Epub 2018 Oct 24.

PMID:
30459115
15.

The interrelations between PCSK9 metabolism and cholesterol synthesis and absorption.

Silbernagel G, Steiner LK, Hollstein T, Fauler G, Scharnagl H, Stojakovic T, Schumann F, Bölükbasi B, März W, Steinhagen-Thiessen E, Laufs U, Kassner U.

J Lipid Res. 2019 Jan;60(1):161-167. doi: 10.1194/jlr.P088583. Epub 2018 Oct 15.

PMID:
30323110
16.

A low-fat spread with added plant sterols and fish omega-3 fatty acids lowers serum triglyceride and LDL-cholesterol concentrations in individuals with modest hypercholesterolaemia and hypertriglyceridaemia.

Blom WAM, Koppenol WP, Hiemstra H, Stojakovic T, Scharnagl H, Trautwein EA.

Eur J Nutr. 2019 Jun;58(4):1615-1624. doi: 10.1007/s00394-018-1706-1. Epub 2018 May 3.

17.

Lysyl oxidase-like protein 2 (LOXL2) modulates barrier function in cholangiocytes in cholestasis.

Pollheimer MJ, Racedo S, Mikels-Vigdal A, Marshall D, Bowlus C, Lackner C, Madl T, Karlsen TH, Hov JR, Lyman SK, Adamkewicz J, Smith V, Moreau E, Zollner G, Eide TJ, Stojakovic T, Scharnagl H, Gruber HJ, Stauber RE, Trauner M, Fickert P.

J Hepatol. 2018 Aug;69(2):368-377. doi: 10.1016/j.jhep.2018.04.009. Epub 2018 Apr 28.

PMID:
29709678
18.

Renal function, N-terminal Pro-B-Type natriuretic peptide, propeptide big-endothelin and patients with heart failure and preserved ejection fraction.

Gergei I, Krämer BK, Scharnagl H, Stojakovic T, März W.

Peptides. 2019 Jan;111:112-117. doi: 10.1016/j.peptides.2018.04.003. Epub 2018 Apr 21.

PMID:
29684593
19.

Vitamin D supplementation and lipoprotein metabolism: A randomized controlled trial.

Schwetz V, Scharnagl H, Trummer C, Stojakovic T, Pandis M, Grübler MR, Verheyen N, Gaksch M, Zittermann A, Aberer F, Lerchbaum E, Obermayer-Pietsch B, Pieber TR, März W, Tomaschitz A, Pilz S.

J Clin Lipidol. 2018 May - Jun;12(3):588-596.e4. doi: 10.1016/j.jacl.2018.03.079. Epub 2018 Mar 15.

PMID:
29653812
20.

Elevated Cardiac Troponin T in Patients With Skeletal Myopathies.

Schmid J, Liesinger L, Birner-Gruenberger R, Stojakovic T, Scharnagl H, Dieplinger B, Asslaber M, Radl R, Beer M, Polacin M, Mair J, Szolar D, Berghold A, Quasthoff S, Binder JS, Rainer PP.

J Am Coll Cardiol. 2018 Apr 10;71(14):1540-1549. doi: 10.1016/j.jacc.2018.01.070.

Supplemental Content

Loading ...
Support Center